Table 1. Clinical data of the patients... | American Society of Hematology

Table 1.

Clinical data of the patients studied

Patient	R/NR	Sex	Age	Stage	Isotype/light chain	CD38 (%)	Sample
1	R	F	80	0	IgM-D/λ	92	PB
2	R	M	65	0	IgG/κ	1	PB
3	R	F	76	0	IgG/λ	6	PB
4	R	M	81	IV	IgM-D/λ	33	PB
5	R	F	53	III-IV	IgM-D/κ	54	BM
6	R	F	64	0	IgM-D/λ	6	PB
7	R	M	67	II	IgM/κ	82	BM
8	R	F	79	III	IgM-D/λ	54	PB
9^*	R	M	84	II	IgM-D/λ	3	PB
10^*	R	F	73	II	IgM-D/λ	97	PB
11	R	M	73	II	IgM-D/κ	39	PB
12	R	M	67	0	IgM-D/κ	85	PB
13	R	F	77	II	IgM-D/κ	2	PB
14	R	M	68	II	IgM-D/κ	25	PB
15	R	F	75	0	IgM-D/κ	66	PB
16	NR	M	72	0	IgM-D/λ	30	PB
17	NR	M	52	IV	IgM-D/κ	1	PB
18	NR	F	67	IV	IgG/κ	6	PB
19	NR	M	67	0	IgM-D/κ	21	PB
20	NR	F	72	IV	IgM-D/κ	94	PB
21	NR	M	84	II	IgM-D/κ	4	PB
22	NR	F	68	0	IgM-D/κ	13	PB
23	ND	M	73	0	IgM/λ	4	PB
24	ND	F	61	0	IgM-D/λ	18	PB
25	ND	F	64	0	IgM/κ	16	BM
26	ND	F	68	0	IgM-D/κ	16	PB
27	ND	M	87	III	IgM-D/κ	21	PB
28	ND	M	70	II	IgM-D/κ	14	PB
29	ND	M	71	II	IgM-D/κ	8	PB
30	ND	M	69	II	IgM-D/λ	10	PB

Patient	R/NR	Sex	Age	Stage	Isotype/light chain	CD38 (%)	Sample
1	R	F	80	0	IgM-D/λ	92	PB
2	R	M	65	0	IgG/κ	1	PB
3	R	F	76	0	IgG/λ	6	PB
4	R	M	81	IV	IgM-D/λ	33	PB
5	R	F	53	III-IV	IgM-D/κ	54	BM
6	R	F	64	0	IgM-D/λ	6	PB
7	R	M	67	II	IgM/κ	82	BM
8	R	F	79	III	IgM-D/λ	54	PB
9^*	R	M	84	II	IgM-D/λ	3	PB
10^*	R	F	73	II	IgM-D/λ	97	PB
11	R	M	73	II	IgM-D/κ	39	PB
12	R	M	67	0	IgM-D/κ	85	PB
13	R	F	77	II	IgM-D/κ	2	PB
14	R	M	68	II	IgM-D/κ	25	PB
15	R	F	75	0	IgM-D/κ	66	PB
16	NR	M	72	0	IgM-D/λ	30	PB
17	NR	M	52	IV	IgM-D/κ	1	PB
18	NR	F	67	IV	IgG/κ	6	PB
19	NR	M	67	0	IgM-D/κ	21	PB
20	NR	F	72	IV	IgM-D/κ	94	PB
21	NR	M	84	II	IgM-D/κ	4	PB
22	NR	F	68	0	IgM-D/κ	13	PB
23	ND	M	73	0	IgM/λ	4	PB
24	ND	F	61	0	IgM-D/λ	18	PB
25	ND	F	64	0	IgM/κ	16	BM
26	ND	F	68	0	IgM-D/κ	16	PB
27	ND	M	87	III	IgM-D/κ	21	PB
28	ND	M	70	II	IgM-D/κ	14	PB
29	ND	M	71	II	IgM-D/κ	8	PB
30	ND	M	69	II	IgM-D/λ	10	PB

B-PLL

R, CD40L-responder; NR, CD40L-nonresponder; ND, not done.